Doping control analysis of small peptides: A decade of progress.
暂无分享,去创建一个
[1] G. N. Leung,et al. DETECTION OF BIOACTIVE PEPTIDES INCLUDING GONADOTROPHIN-RELEASING FACTORS (GnRHs) IN HORSE URINE USING ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRY (UHPLC/HRMS). , 2020, Drug testing and analysis.
[2] M. Thevis,et al. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS , 2020, Analytical and Bioanalytical Chemistry.
[3] J. Coumbaros,et al. Dispersive SPE, an alternative to traditional SPE for extraction of 43 doping peptides from equine urine prior to LC–MS screening , 2020, Forensic Toxicology.
[4] M. Thevis,et al. Analytical Approaches in Human Sports Drug Testing - Recent Advances, Challenges, and Solutions. , 2020, Analytical Chemistry.
[5] I. Zamora,et al. Software-aided workflow for predicting protease-specific cleavage sites using physicochemical properties of the natural and unnatural amino acids in peptide-based drug discovery , 2018, bioRxiv.
[6] M. Thevis,et al. Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review. , 2018, Drug testing and analysis.
[7] Laura Orsatti,et al. A liquid chromatography high‐resolution mass spectrometry in vitro assay to assess metabolism at the injection site of subcutaneously administered therapeutic peptides , 2018, Journal of pharmaceutical and biomedical analysis.
[8] Hong Yang,et al. Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability. , 2018, Current drug metabolism.
[9] K. Deventer,et al. Urinary matrix effects in electrospray ionization mass spectrometry in the presence of DMSO. , 2018, Journal of mass spectrometry : JMS.
[10] M. Popławska,et al. Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial. , 2018, Drug testing and analysis.
[11] A. Sickmann,et al. Analysis of new growth promoting black market products. , 2018, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[12] L. Pickart,et al. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data , 2018, International journal of molecular sciences.
[13] M. Moon,et al. Development of a multi-functional concurrent assay using weak cation-exchange solid-phase extraction (WCX-SPE) and reconstitution with a diluted sample aliquot for anti-doping analysis. , 2018, Rapid communications in mass spectrometry : RCM.
[14] K. Deventer,et al. Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: Fast screening of peptides and organic molecules. , 2018, Journal of mass spectrometry : JMS.
[15] J. Loo,et al. Enhancing Sensitivity of Liquid Chromatography-Mass Spectrometry of Peptides and Proteins Using Supercharging Agents. , 2017, International journal of mass spectrometry.
[16] M. Fernández-Álvarez,et al. Determination of doping peptides via solid-phase microelution and accurate-mass quadrupole time-of-flight LC-MS. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] D. Eichner,et al. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. , 2017, Drug testing and analysis.
[18] M. Thevis,et al. Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports. , 2017, Drug testing and analysis.
[19] Jolene L. Lau,et al. Therapeutic peptides: Historical perspectives, current development trends, and future directions. , 2017, Bioorganic & medicinal chemistry.
[20] P. J. Pedersen,et al. Absorption, metabolism and excretion of the GLP‐1 analogue semaglutide in humans and nonclinical species , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] R. Hoffmann,et al. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum , 2017, PloS one.
[22] K. Deventer,et al. DMSO Assisted Electrospray Ionization for the Detection of Small Peptide Hormones in Urine by Dilute-and-Shoot-Liquid-Chromatography-High Resolution Mass Spectrometry , 2017, Journal of The American Society for Mass Spectrometry.
[23] A. Sanchez,et al. Bioactive peptides: A review , 2017 .
[24] J. Segura,et al. Detection of Growth Hormone Releasing Peptides in Serum by aCompetitive Receptor Binding Assay , 2017 .
[25] M. Thevis,et al. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. , 2016, Journal of pharmaceutical and biomedical analysis.
[26] G. Rodchenkov,et al. Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction. , 2016, Journal of proteomics.
[27] G. Rodchenkov,et al. Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine. , 2016, Drug testing and analysis.
[28] P. Heining,et al. The Use of Minipig in Drug Discovery and Development , 2016, Toxicologic pathology.
[29] J. Veuthey,et al. Analytical Strategies for Doping Control Purposes: Needs, Challenges, and Perspectives. , 2016, Analytical chemistry.
[30] L. Khawli,et al. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development , 2015, mAbs.
[31] M. Thevis,et al. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. , 2015, Drug testing and analysis.
[32] M. Farré,et al. Fit-for-Purpose Radio Receptor Assay for the Determination of Growth Hormone Secretagogues in Urine , 2015, Journal of biomolecular screening.
[33] F. Botrè,et al. Development and validation of a liquid chromatography–mass spectrometry procedure after solid-phase extraction for detection of 19 doping peptides in human urine , 2015, Forensic Toxicology.
[34] A. Nongonierma,et al. Improved short peptide identification using HILIC-MS/MS: retention time prediction model based on the impact of amino acid position in the peptide sequence. , 2015, Food chemistry.
[35] Joël Richard,et al. Challenges in the delivery of peptide drugs: an industry perspective. , 2015, Therapeutic delivery.
[36] K. Deventer,et al. In vitro models for metabolic studies of small peptide hormones in sport drug testing , 2015, Journal of peptide science : an official publication of the European Peptide Society.
[37] A. Elaissari,et al. Administration strategies for proteins and peptides. , 2014, International journal of pharmaceutics.
[38] Wilhelm Schänzer,et al. Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions , 2014, Expert review of proteomics.
[39] J. Vine,et al. A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography. , 2014, Drug testing and analysis.
[40] J. Vine,et al. A high throughput screen for 17 Dermorphin peptides in equine and human urine and equine plasma. , 2014, Drug testing and analysis.
[41] A. Beck‐Sickinger,et al. Automated solid-phase peptide synthesis to obtain therapeutic peptides , 2014, Beilstein journal of organic chemistry.
[42] David Handelsman,et al. Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[43] M. Sarwal,et al. Optimization for peptide sample preparation for urine peptidomics , 2014, Clinical Proteomics.
[44] Nageswara Rao Pilli,et al. Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC–MS/MS☆ , 2013, Journal of pharmaceutical analysis.
[45] Bernhard Kuster,et al. DMSO enhances electrospray response, boosting sensitivity of proteomic experiments , 2013, Nature Methods.
[46] G. N. Leung,et al. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography–mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.
[47] D. Craik,et al. The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.
[48] T. Wan,et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. , 2012, Journal of chromatography. A.
[49] M. Thevis,et al. Metabolism of growth hormone releasing peptides. , 2012, Analytical chemistry.
[50] M. Thevis,et al. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. , 2012, Journal of chromatography. A.
[51] K. Deventer,et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. , 2012, Drug testing and analysis.
[52] Stephanie Smith,et al. Small Signaling Peptides in Arabidopsis Development: How Cells Communicate Over a Short Distance , 2012, Plant Cell.
[53] M. Thevis,et al. Analytical challenges in the detection of peptide hormones for anti-doping purposes. , 2012, Bioanalysis.
[54] Xinmiao Liang,et al. Two-dimensional liquid chromatography separation of peptides using reversed-phase/weak cation-exchange mixed-mode column in first dimension. , 2012, Journal of chromatography. A.
[55] M. Meyer,et al. Current applications of high-resolution mass spectrometry in drug metabolism studies , 2012, Analytical and Bioanalytical Chemistry.
[56] K. Deventer,et al. Qualitative detection of desmopressin in plasma by liquid chromatography–tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.
[57] Ilkka Ojanperä,et al. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.
[58] Wilhelm Schänzer,et al. Doping control analysis of selected peptide hormones using LC-MS(/MS). , 2011, Forensic science international.
[59] M. Thevis,et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[60] M. Zdravkovic,et al. Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase , 2010, Drug Metabolism and Disposition.
[61] S. Kageyama,et al. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.
[62] I. Marc,et al. Modeling the separation of small peptides by cation-exchange chromatography. , 2010, Journal of separation science.
[63] S. Kageyama,et al. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[64] Jiunn H Lin,et al. Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies. , 2009, Current drug metabolism.
[65] M. Thevis,et al. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. , 2008, Journal of mass spectrometry : JMS.
[66] E. Bardaji,et al. Synthetic Antimicrobial Peptides as Agricultural Pesticides for Plant‐Disease Control , 2008, Chemistry & biodiversity.
[67] G. Merriam,et al. Growth hormone (GH)–releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus? , 2008, Clinical interventions in aging.
[68] M. Thevis,et al. Emerging drugs--potential for misuse in sport and doping control detection strategies. , 2007, Mini reviews in medicinal chemistry.
[69] Wilhelm Schänzer,et al. Current role of LC-MS(/MS) in doping control , 2007, Analytical and bioanalytical chemistry.
[70] D. Armstrong,et al. Analysis of native amino acid and peptide enantiomers by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. , 2004, Journal of mass spectrometry : JMS.
[71] G. Irvine. High-performance size-exclusion chromatography of peptides. , 2003, Journal of biochemical and biophysical methods.
[72] C. Rehfeldt,et al. Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[73] V. D. Hoang,et al. Characterization of human nasal primary culture systems to investigate peptide metabolism. , 2002, International journal of pharmaceutics.
[74] E. Williams,et al. Effects of solvent on the maximum charge state and charge state distribution of protein ions produced by electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.
[75] M. Hennion. Solid-phase extraction: method development, sorbents, and coupling with liquid chromatography. , 1999, Journal of chromatography. A.
[76] B. Rode,et al. Peptides and the origin of life1 , 1999, Peptides.
[77] Mario Thevis,et al. Recent advances in the determination of insulins from biological fluids. , 2019, Advances in clinical chemistry.
[78] D. Jaradat. Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation , 2017, Amino Acids.
[79] J. Segura,et al. Structure-activity relationship for peptídic growth hormone secretagogues. , 2017, Drug testing and analysis.
[80] I. Zvereva,et al. Determination of GnRH and its synthetic analogues' abuse in doping control: Small bioactive peptide UPLC-MS/MS method extension by addition of in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameter fluctuations as suitable biomarkers. , 2018, Drug testing and analysis.
[81] M. Thevis,et al. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. , 2016, Journal of separation science.
[82] D. Eichner,et al. Detection and in vitro metabolism of AOD9604. , 2015, Drug testing and analysis.
[83] Li Di,et al. Strategic Approaches to Optimizing Peptide ADME Properties , 2014, The AAPS Journal.
[84] P. Varamini,et al. Gonadotropin Releasing Hormone , 2014 .
[85] Ó. Pozo,et al. Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism , 2014 .
[86] T. Katsila,et al. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry. , 2012, Mass spectrometry reviews.
[87] J. Segura,et al. Growth hormone secretagogues: out of competition , 2011, Analytical and Bioanalytical Chemistry.
[88] Atsushi. Tsukamoto,et al. Rapid peptide separation by supercritical fluid chromatography. , 2010, Bioanalysis.
[89] J. Boyle. Lehninger principles of biochemistry (4th ed.): Nelson, D., and Cox, M. , 2005 .
[90] D. Le Roith,et al. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. , 2001, Annual review of physiology.